Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy

NCT06542757 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: 1.5 T Elekta Unity MR-Linac system
DEVICE: Hydrogel rectal spacer (SpaceOAR)

Sponsor

NYU Langone Health